BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26925795)

  • 21. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Verbascoside Attenuates Rac-1 and HIF-1α Signaling Cascade in Colorectal Cancer Cells.
    Seyfi D; Behzad SB; Nabiuni M; Parivar K; Tahmaseb M; Amini E
    Anticancer Agents Med Chem; 2018; 18(15):2149-2155. PubMed ID: 29886834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhapontigenin inhibits TGF-β-mediated epithelial‑mesenchymal transition via the PI3K/AKT/mTOR pathway and is not associated with HIF-1α degradation.
    Yeh YH; Wang SW; Yeh YC; Hsiao HF; Li TK
    Oncol Rep; 2016 May; 35(5):2887-95. PubMed ID: 26986649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.
    Wang H; Zhang C; Xu L; Zang K; Ning Z; Jiang F; Chi H; Zhu X; Meng Z
    Oncotarget; 2016 Apr; 7(15):20193-208. PubMed ID: 26958938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herbal prescription, Danggui-Sayuk-Ga-Osuyu-Senggang-Tang, inhibits TNF-α-induced epithelial-mesenchymal transition in HCT116 colorectal cancer cells.
    Lee K; Cho SG; Choi YK; Choi YJ; Lee GR; Jeon CY; Ko SG
    Int J Mol Med; 2018 Jan; 41(1):373-380. PubMed ID: 29115450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells.
    Bocca C; Bozzo F; Cannito S; Parola M; Miglietta A
    Mol Carcinog; 2012 Oct; 51(10):783-95. PubMed ID: 21882253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail/Twist-mediated epithelial-mesenchymal transition.
    Li S; Zhang J; Yang H; Wu C; Dang X; Liu Y
    Sci Rep; 2015 Jul; 5():12410. PubMed ID: 26174737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIF-1α/Ascl2/miR-200b regulatory feedback circuit modulated the epithelial-mesenchymal transition (EMT) in colorectal cancer cells.
    Shang Y; Chen H; Ye J; Wei X; Liu S; Wang R
    Exp Cell Res; 2017 Nov; 360(2):243-256. PubMed ID: 28899657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia facilitates epithelial-mesenchymal transition-mediated rectal cancer progress.
    Sun LL; Song Z; Li WZ; Tang SY
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 27966740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-Tumor Effects of Paeoniflorin on Epithelial-To-Mesenchymal Transition in Human Colorectal Cancer Cells.
    Zhang JW; Li LX; Wu WZ; Pan TJ; Yang ZS; Yang YK
    Med Sci Monit; 2018 Sep; 24():6405-6413. PubMed ID: 30208371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of hypoxia inducible factor-1α downregulates the expression of epithelial to mesenchymal transition early marker proteins without undermining cell survival in hypoxic lens epithelial cells.
    Cammarata PR; Neelam S; Brooks MM
    Mol Vis; 2015; 21():1024-35. PubMed ID: 26392741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
    Sun Y; Wang H; Liu M; Lin F; Hua J
    Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells.
    Azimi I; Milevskiy MJG; Kaemmerer E; Turner D; Yapa KTDS; Brown MA; Thompson EW; Roberts-Thomson SJ; Monteith GR
    J Cell Sci; 2017 Jul; 130(14):2292-2305. PubMed ID: 28559303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
    Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
    Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
    Abouhashem NS; Ibrahim DA; Mohamed AM
    Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plantamajoside inhibits hypoxia-induced migration and invasion of human cervical cancer cells through the NF-κB and PI3K/akt pathways.
    Zuo X; Li L; Sun L
    J Recept Signal Transduct Res; 2021 Aug; 41(4):339-348. PubMed ID: 32865085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dual PI3K/mTOR inhibitor NVP-BEZ235 prevents epithelial-mesenchymal transition induced by hypoxia and TGF-β1.
    Lin G; Gai R; Chen Z; Wang Y; Liao S; Dong R; Zhu H; Gu Y; He Q; Yang B
    Eur J Pharmacol; 2014 Apr; 729():45-53. PubMed ID: 24561043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
    Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
    Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
    Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
    Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.